Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 3
111
Views
5
CrossRef citations to date
0
Altmetric
Case Studies

Effectiveness of pregabalin as a secondary treatment for neuropathic pain from postherpetic neuralgia

, BSORCID Icon & , DVM, PhD
Pages 469-470 | Received 05 Apr 2020, Accepted 07 May 2020, Published online: 29 May 2020

  • Devor M. Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: the ectopic pacemaker hypothesis. Pain Rep. 2018;3:e702. doi:10.1097/PR9.0000000000000702.
  • Gudin J, Fudin J, Wang E, Haylon T, Patel K, Goss TF. Treatment patterns and medication use in patients with postherpetic neuralgia. J Manag Care Spec Pharm. 2019;25:1387–1396. doi:10.18553/jmcp.2019.19093.
  • Baidya DK, Agarwal A, Khanna P, Arora MK. Pregabalin in acute and chronic pain. J Anaesthesiol Clin Pharmacol. 2011;27:307–314. doi:10.4103/0970-9185.83672.
  • Dahl JB, Mathiesen O, Møiniche S. “Protective premedication”: an option with gabapentin and related drugs? A review of gabapentin and pregabalin in the treatment of post-operative pain. Acta Anaesthesiol Scand. 2004;48:1130–1136. doi:10.1111/j.1399-6576.2004.00484.x.
  • Gilron I, Biederman J, Jhamandas K, Hong M. Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests. Anesthesiology. 2003;98:1288–1292. doi:10.1097/00000542-200305000-00037.
  • Hansen C, Gilron I, Hong M. The effects of intrathecal gabapentin on spinal morphine tolerance in the rat tail-flick and paw pressure tests. Anesth Analg. 2004;99:1180–1184. doi:10.1213/01.ANE.0000130383.87438.A9.
  • Rowbotham DJ. Gabapentin: a new drug for postoperative pain? Br J Anaesth. 2006;96:152–155. doi:10.1093/bja/aei318.
  • Turan A, Kaya G, Karamanlioğlu B, Pamukçu Z, Apfel CC. Effect of oral gabapentin on postoperative epidural analgesia. Br J Anaesth. 2006;96:242–246. doi:10.1093/bja/aei294.
  • Smith KJ, Roberts MS. Sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis. J Pain. 2007;8:396–404. doi:10.1016/j.jpain.2006.11.005.
  • Tarride J-E, Gordon A, Vera-Llonch M, Dukes E, Rousseau C. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective. Clin Ther. 2006;28:1922–1934. doi:10.1016/j.clinthera.2006.11.017.
  • Parsons B, Whalen E, Brown PB, Ortiz M, Knapp L, Behar R. Relationship between euphoria and early treatment response to pregabalin in patients with chronic pain. J Pain. 2017;18:S77. doi:10.1016/j.jpain.2017.02.261.
  • Freedman B, Ohara E. Pregabalin has opioid-sparing effects following augmentation mammaplasty. Aesthet Surg J. 2008;28:421–424. doi:10.1016/j.asj.2008.04.004.
  • US Food and Drug Administration. FDA approves first generics of Lyrica [press release]. https://www.fda.gov/news-events/press-announcements/fda-approves-first-generics-lyrica. Published July 22, 2019. Accessed April 30, 2020.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.